PLAA expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.57474075183018E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.44920022835538E-10 |
Normal-vs-Stage2 |
3.55530000000215E-05 |
Normal-vs-Stage3 |
1.13864473405556E-12 |
Normal-vs-Stage4 |
3.01489999632309E-09 |
Stage1-vs-Stage2 |
7.608000E-01 |
Stage1-vs-Stage3 |
1.044220E-02 |
Stage1-vs-Stage4 |
8.728500E-02 |
Stage2-vs-Stage3 |
2.078000E-01 |
Stage2-vs-Stage4 |
3.440000E-01 |
Stage3-vs-Stage4 |
8.483600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.73221503386412E-13 |
Normal-vs-AfricanAmerican |
5.67769997683598E-09 |
Normal-vs-Asian |
6.379200E-01 |
Caucasian-vs-AfricanAmerican |
4.728400E-01 |
Caucasian-vs-Asian |
3.352200E-01 |
AfricanAmerican-vs-Asian |
2.710400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.88418203051333E-15 |
Normal-vs-Female |
2.75300000018852E-07 |
Male-vs-Female |
4.840400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.93316000000054E-05 |
Normal-vs-Age(41-60Yrs) |
1.40250033808798E-10 |
Normal-vs-Age(61-80Yrs) |
1.74227299254426E-12 |
Normal-vs-Age(81-100Yrs) |
1.25609999956922E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.001000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.750400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.920800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.828400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.738400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.927000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.421900E-02 |
Normal-vs-Grade 2 |
8.55530002397131E-09 |
Normal-vs-Grade 3 |
1.70041758451589E-12 |
Normal-vs-Grade 4 |
5.75789971257734E-10 |
Grade 1-vs-Grade 2 |
3.260200E-01 |
Grade 1-vs-Grade 3 |
3.505900E-02 |
Grade 1-vs-Grade 4 |
5.144300E-02 |
Grade 2-vs-Grade 3 |
3.582000E-03 |
Grade 2-vs-Grade 4 |
8.865000E-03 |
Grade 3-vs-Grade 4 |
5.401200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.23510000005211E-06 |
Normal-vs-ccB subtype |
2.81474843433216E-12 |
ccA subtype-vs-ccB subtype |
1.075800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.40879546811834E-11 |
Normal-vs-N1 |
5.167700E-02 |
N0-vs-N1 |
9.081200E-01 |
|
|